Effects of the anaesthetic/tranquillizer treatments on selected plasma biochemical parameters in NZW XXXX .

@entity3175 @entity6918 @entity95 @entity3652 @entity38099 @entity4763 @entity1391 @entity972 @entity1011 @entity731 @entity3575
In order to assess the response of plasma biochemical parameters to anaesthesia, 40 New Zealand White (NZW) @entity95 were assigned to four treatment groups (n = 10): control (1 ml i.v. saline solution), @entity38099 (FD) (0.4 ml/kg s.c. of 'thalamonal' solution; 2.5 mg/ml @entity6918 , 0.05 mg/ml @entity3575 ), @entity3652 (K) (10 mg/kg i.v.) with either @entity4763 (X) (3 mg/kg i.v.) or @entity3175 (D) (2 mg/kg i.v.). Blood samples were obtained from the central ear artery at six time points: before injection, and at 10, 30, 60, 120 min and 24 h after injection of the anaesthetics/saline. Plasma ALT, AST, @entity731 , GGT, BUN, @entity1011 , @entity1391 and @entity972 levels were measured by the Hitachi 747 autoanalyser. The administration of K-X increased (P < 0.05) plasma ALT (from 11.4 +/- 0.9 to 20.2 +/- 1.7 IU/l, at 10 min), AST (from 10.5 +/- 3.3 to 34 +/- 2.1 IU/l, at 120 min), BUN (from 17.2 +/- 0.9 to 25.8 +/- 1.8 mg/dl, at 60 min) and @entity1011 concentrations (from 1 +/- 0.1 to 1.6 +/- 0.2 mg/dl, at 10 min). After K-D administration, we observed an increase (P < 0.05) in plasma ALT (from 11.4 +/- 0.9 to 20.2 +/- 1.1 IU/l, at 10 min), AST (from 11.4 +/- 1.6 to 28 +/- 3.7 IU/l, at 10 min), BUN (from 15.8 +/- 0.8 to 30 +/- 1.5 mg/dl, at 10 min) and @entity1011 levels (from 1 +/- 0.08 to 2.2 +/- 0.2 mg/dl, at 120 min). No significant changes were seen in the FD group. We conclude that K-X and K-D may affect plasma concentration of select serum enzymes and biochemical parameters. These results should be taken into account when blood samples are evaluated in treated @entity95 .
